Metharom E - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Modulation of gemcitabine accumulation by DNA-damaging agents: mechanisms and specificity in an in vitro model.

Metharom E, Galettis P, Manners S, Links M. Metharom E, et al. Anticancer Res. 2010 Sep;30(9):3669-73. Anticancer Res. 2010. PMID: 20944152

Randomized crossover study evaluating the effect of gemcitabine infusion dose rate: evidence of auto-induction of gemcitabine accumulation.

Grimison P, Galettis P, Manners S, Jelinek M, Metharom E, de Souza PL, Liauw W, Links MJ. Grimison P, et al. Among authors: metharom e. J Clin Oncol. 2007 Dec 20;25(36):5704-9. doi: 10.1200/JCO.2007.10.7078. J Clin Oncol. 2007. PMID: 18089865 Clinical Trial.

The pharmacological advantage of prolonged dose rate gemcitabine is restricted to patients with variant alleles of cytidine deaminase c.79A>C.

Metharom E, Galettis P, Manners S, Jelinek M, Liauw W, de Souza PL, Hoskins JM, Links M. Metharom E, et al. Asia Pac J Clin Oncol. 2011 Mar;7(1):65-74. doi: 10.1111/j.1743-7563.2010.01354.x. Epub 2010 Dec 30. Asia Pac J Clin Oncol. 2011. PMID: 21332653 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters